Maryland Capital Management Abbott Laboratories Transaction History

Maryland Capital Management

$1.2 Billion
Q3 2022

A detailed history of Maryland Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Maryland Capital Management holds 185,019 shares of ABT stock, worth $21.7 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares

185,019

Previous 189,349 2.29%

Holding current value

$21.7 Million

Previous $20.6 Million 12.98%

% of portfolio

1.49%

Previous 1.62%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $418,970 - $485,089	-4,330 Reduced 2.29%	185,019 $17.9 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $515,351 - $622,895	-5,049 Reduced 2.6%	189,349 $20.6 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $22.6 Million - $27.5 Million	-198,136 Reduced 50.48%	194,398 $23 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $119,342 - $146,128	-1,033 Reduced 0.26%	392,534 $55.2 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $585,983 - $648,268	-5,023 Reduced 1.26%	393,567 $46.5 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $1.39 Million - $1.64 Million	13,185 Added 3.42%	398,590 $46.2 Million
Q1 2021 May 11, 2021	BUY	$108.84 - $128.23 $219,965 - $259,152	2,021 Added 0.53%	385,405 $46.2 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $1.14 Million - $1.24 Million	10,841 Added 2.91%	383,384 $42 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $499,254 - $606,307	5,448 Added 1.48%	372,543 $40.5 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $548,317 - $701,778	7,161 Added 1.99%	367,095 $33.6 Million
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $732,732 - $1.07 Million	11,664 Added 3.35%	359,934 $28.4 Million
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $86,753 - $96,577	-1,105 Reduced 0.32%	348,270 $30.3 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $14,567 - $15,795	-178 Reduced 0.05%	349,375 $29.2 Million
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $419,424 - $489,175	-5,755 Reduced 1.62%	349,553 $29.4 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $90,588 - $109,522	-1,368 Reduced 0.38%	355,308 $28.4 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $40,712 - $46,121	621 Added 0.17%	356,676 $25.8 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $162,909 - $196,531	-2,679 Reduced 0.75%	356,055 $26.1 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $243,808 - $269,091	-4,235 Reduced 1.17%	358,734 $21.9 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $621,896 - $703,128	-11,052 Reduced 2.95%	362,969 $21.7 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $547,750 - $586,423	-10,204 Reduced 2.66%	374,021 $21.3 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $1.63 Million - $1.82 Million	-34,007 Reduced 8.13%	384,225 $20.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	418,232	418,232 $20.3 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Maryland Capital Management with notifications on news.

Account

Maryland Capital Management Abbott Laboratories Transaction History